LEUPROLIDE ACETATE FOR DEPOT SUSPENSION Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Leuprolide Acetate For Depot Suspension, and when can generic versions of Leuprolide Acetate For Depot Suspension launch?
Leuprolide Acetate For Depot Suspension is a drug marketed by Invagen Pharms and is included in one NDA.
The generic ingredient in LEUPROLIDE ACETATE FOR DEPOT SUSPENSION is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Leuprolide Acetate For Depot Suspension
A generic version of LEUPROLIDE ACETATE FOR DEPOT SUSPENSION was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION?
- What are the global sales for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION?
- What is Average Wholesale Price for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION?
Summary for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 6 |
| DailyMed Link: | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION at DailyMed |
Recent Clinical Trials for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Myovant Sciences GmbH | Phase 3 |
| Tolmar Inc. | Phase 3 |
| Oakwood Laboratories, LLC | Phase 3 |
See all LEUPROLIDE ACETATE FOR DEPOT SUSPENSION clinical trials
US Patents and Regulatory Information for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
See the table below for patents covering LEUPROLIDE ACETATE FOR DEPOT SUSPENSION around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 2169980 | MICROCAPSULAS PARA LA LIBERACION PROLONGADA DE FARMACOS. | ⤷ Sign Up |
| Spain | 2194793 | ⤷ Sign Up | |
| Japan | 2003516960 | ⤷ Sign Up | |
| Austria | 234608 | ⤷ Sign Up | |
| European Patent Office | 1151746 | MICROCAPSULES POUR LA LIBERATION PROLONGEE DE MEDICAMENTS (MICROCAPSULES FOR SUSTAINED RELEASE OF DRUGS) | ⤷ Sign Up |
| Japan | 5021880 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
